Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics™, a science-first, health care technology company, today announced that a key piece of its BetterWay™ Blood Testing ecosystem has achieved 510(k) ...

A team led by La Trobe University has drawn inspiration from nature to develop a breakthrough sensor that can rapidly track ...

Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...

(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX), and health care technology company Babson Diagnostics, announced Tuesday an expansion of fingertip blood collection and ...

The survey results reveal strong enthusiasm for blood-based screening options among adults aged 45 and older, the group ...

A cell-mimicking nanosensor uses lubricin and SERS to detect drugs in whole blood in real time, resisting fouling for over 10 hours of continuous monitoring.

With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...